{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Matuzumab",
  "nciThesaurus": {
    "casRegistry": "339186-68-4",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, competitively blocking natural ligand binding and inhibiting receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation.",
    "fdaUniiCode": "MG4M3QB242",
    "identifier": "C2012",
    "preferredName": "Matuzumab",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C20401"
    ],
    "synonyms": [
      "EMD 72000",
      "MATUZUMAB",
      "Matuzumab",
      "matuzumab"
    ]
  }
}